Effects of carbenoxolone on the gastric mucosal prostaglandin and thromboxane system.
D011452:15-Oxoprostaglandin 13-Reductase / Q000037:antagonists & inhibitors; D000818:Animals; D002229:Carbenoxolone / Q000494:pharmacology*; D005753:Gastric Mucosa / Q000187:drug effects*; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives*; D006801:Humans; D006911:Hydroxyprostaglandin Dehydrogenases / Q000037:antagonists & inhibitors; D066298:In Vitro Techniques; D011453:Prostaglandins / Q000096:biosynthesis*; D051381:Rats; D013928:Thromboxane A2 / Q000037:antagonists & inhibitors*; D013929:Thromboxane B2 / Q000037:antagonists & inhibitors; D013931:Thromboxanes / Q000037:antagonists & inhibitors*
D011453:Prostaglandins; D013931:Thromboxanes; D013929:Thromboxane B2; D013928:Thromboxane A2; D006911:Hydroxyprostaglandin Dehydrogenases; D011452:15-Oxoprostaglandin 13-Reductase; D002229:Carbenoxolone; D006034:Glycyrrhetinic Acid